Patent · US Active

Use and treatment of di-amino acid repeat-containing proteins associated with ALS

US11035867B2 · kind B2 · utility

0Cited by
9References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 17, 2020
Grant dateJun 15, 2021
Priority date
Expiry dateApr 17, 2040

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/285
  • WIPO fieldChemical engineering
  • WIPO sectorChemistry

Abstract

Disclosed herein are methods and compositions for identifying and/or treating subjects having or likely to have amyotrophic lateral sclerosis (ALS) or frontotemporal dementia (FTD). Antibodies specific for one or more di-amino acid repeat-containing proteins are also provided herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.